Publications by authors named "Victoria R Polonis"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

180,291

Total Likes

4,088

Extended Reach

519,812

Social Features

119
F
First-generation N-terminal domain supersite public antibodies retain activity against Omicron-derived lineages and protect mice against Omicron BA.5 challenge.
Vincent Dussupt, Jaime L Jensen, Paul V Thomas, Letzibeth Mendez-Rivera, Kerri G Lal, Victoria R Polonis

mBio· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Production of Clinical-Grade SARS-CoV-2 Spike Ferritin Nanoparticle Protein Immunogen by Transient Transfection.
Agnes Hajduczki, William C Chang, Rafael De La Barrera, James F Wood, Wei-Hung Chen, Victoria R Polonis

Vaccines (Basel)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transmission of highly virulent CXCR4 tropic HIV-1 through the mucosal route in an individual with a wild-type CCR5 genotype.
Manukumar Honnayakanahalli Marichannegowda, Saini Setua, Meera Bose, Eric Sanders-Buell, David King, Victoria R Polonis

EBioMedicine· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extracellular vesicle isolation methods identify distinct HIV-1 particles released from chronically infected T-cells.
Sebastian M Molnar, Yuriy Kim, Lindsay Wieczorek, Anastasia Williams, Kajal Ashok Patil, Victoria R Polonis

J Extracell Vesicles· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in neutralizing antibody sensitivities and envelope characteristics indicate distinct antigenic properties of Nigerian HIV-1 subtype G and CRF02_AG.
Lindsay Wieczorek, David Chang, Eric Sanders-Buell, Michelle Zemil, Elizabeth Martinez, Victoria R Polonis

Virol J· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innate immune cell activation after HIV-1 vaccine administration is associated with increased antibody production.
Kombo F N'guessan, Kawthar Machmach, Isabella Swafford, Margaret C Costanzo, Lindsay Wieczorek, Victoria R Polonis

Front Immunol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody targeting of conserved sites of vulnerability on the SARS-CoV-2 spike receptor-binding domain.
Rajeshwer S Sankhala, Vincent Dussupt, Wei-Hung Chen, Hongjun Bai, Elizabeth J Martinez, Victoria R Polonis

Structure· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques.
Rajeshwer S Sankhala, Kerri G Lal, Jaime L Jensen, Vincent Dussupt, Letzibeth Mendez-Rivera, Victoria R Polonis

Nat Commun· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tracking coreceptor switch of the transmitted/founder HIV-1 identifies co-evolution of HIV-1 antigenicity, coreceptor usage and CD4 subset targeting: the RV217 acute infection cohort study.
Manukumar Honnayakanahalli Marichannegowda, Michelle Zemil, Lindsay Wieczorek, Eric Sanders-Buell, Meera Bose, Victoria R Polonis

EBioMedicine· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of HIV-1 envelope towards reduced neutralization sensitivity, as demonstrated by contemporary HIV-1 subtype B from the United States.
Lindsay Wieczorek, Eric Sanders-Buell, Michelle Zemil, Eric Lewitus, Erin Kavusak, Victoria R Polonis

PLoS Pathog· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transmission of highly virulent CXCR4 tropic HIV-1 through the mucosal route in an individual with a wild-type CCR5 genotype.
Manukumar Honnayakanahalli Marichannegowda, Saini Setua, Meera Bose, Eric Sanders-Buell, David King, Victoria R Polonis

bioRxiv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity.
Jaime L Jensen, Rajeshwer S Sankhala, Vincent Dussupt, Hongjun Bai, Agnes Hajduczki, Victoria R Polonis

J Virol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALVAC-HIV and AIDSVAX B/E vaccination induce improved immune responses compared with AIDSVAX B/E vaccination alone.
Margaret C Costanzo, Dominic Paquin-Proulx, Alexandra Schuetz, Siriwat Akapirat, Zhanna Shubin, Victoria R Polonis

JCI Insight· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Convalescent human IgG, but not IgM, from COVID-19 survivors confers dose-dependent protection against SARS-CoV-2 replication and disease in hamsters.
Hannah A D King, Vincent Dussupt, Letzibeth Mendez-Rivera, Bonnie M Slike, Ursula Tran, Victoria R Polonis

Front Immunol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity.
Wei-Hung Chen, Agnes Hajduczki, Elizabeth J Martinez, Hongjun Bai, Hanover Matz, Victoria R Polonis

Nat Commun· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of Antibody Responses in HIV-1 CRF01_AE Acute Infection: Founder Envelope V1V2 Impacts the Timing and Magnitude of Autologous Neutralizing Antibodies.
Syna Kuriakose Gift, Lindsay Wieczorek, Eric Sanders-Buell, Michelle Zemil, Sebastian Molnar, Victoria R Polonis

J Virol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tracking coreceptor switch of the transmitted/founder HIV-1 identifies co-evolution of HIV-1 antigenicity, coreceptor usage and CD4 subset targeting.
Manukumar Honnayakanahalli Marichannegowda, Michelle Zemil, Lindsay Wieczorek, Eric Sanders-Buell, Meera Bose, Victoria R Polonis

bioRxiv· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fc receptor engagement of HIV-1 Env-specific antibodies in mothers and infants predicts reduced vertical transmission.
Brittani M Barrows, Shelly J Krebs, Ningbo Jian, Michelle Zemil, Bonnie M Slike, Victoria R Polonis

Front Immunol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Antibody-Dependent Fc-Mediated Viral Entry, as Compared With Neutralization, in SARS-CoV-2 Infection.
Lindsay Wieczorek, Michelle Zemil, Mélanie Merbah, Vincent Dussupt, Erin Kavusak, Victoria R Polonis

Front Immunol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV-1 infections with multiple founders associate with the development of neutralization breadth.
Eric Lewitus, Samantha M Townsley, Yifan Li, Gina C Donofrio, Bethany L Dearlove, Victoria R Polonis

PLoS Pathog· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-HIV antibody development up to 1 year after antiretroviral therapy initiation in acute HIV infection.
Julie L Mitchell, Justin Pollara, Kenneth Dietze, R Whitney Edwards, Junsuke Nohara, Victoria R Polonis

J Clin Invest· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations.
Vincent Dussupt, Rajeshwer S Sankhala, Letzibeth Mendez-Rivera, Samantha M Townsley, Fabian Schmidt, Victoria R Polonis

Nat Immunol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity.
M Gordon Joyce, Wei-Hung Chen, Rajeshwer S Sankhala, Agnes Hajduczki, Paul V Thomas, Victoria R Polonis

Cell Rep· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge.
Kathryn McGuckin Wuertz, Erica K Barkei, Wei-Hung Chen, Elizabeth J Martinez, Ines Lakhal-Naouar, Victoria R Polonis

NPJ Vaccines· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis